Meros Investment Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $408K | Buy |
919,945
+125,265
| +16% | +$55.6K | 0.19% | 40 |
|
|
2025
Q1 | $450K | Sell |
794,680
-19,027
| -2% | -$10.8K | 0.26% | 38 |
|
|
2024
Q4 | $1.72M | Sell |
813,707
-19,882
| -2% | -$42K | 0.77% | 36 |
|
|
2024
Q3 | $2.24M | Sell |
833,589
-1,624
| -0.2% | -$4.37K | 1.01% | 36 |
|
|
2024
Q2 | $2.38M | Buy |
835,213
+13,421
| +2% | +$38.3K | 1.13% | 34 |
|
|
2024
Q1 | $3.48M | Buy |
821,792
+2,042
| +0.2% | +$8.66K | 1.56% | 29 |
|
|
2023
Q4 | $4.39M | Buy |
819,750
+12,633
| +2% | +$67.6K | 2.08% | 22 |
|
|
2023
Q3 | $3.47M | Sell |
807,117
-5,897
| -0.7% | -$25.4K | 1.89% | 25 |
|
|
2023
Q2 | $4.46M | Sell |
813,014
-311,192
| -28% | -$1.71M | 2.21% | 24 |
|
|
2023
Q1 | $4.72M | Sell |
1,124,206
-12,639
| -1% | -$53.1K | 2.69% | 18 |
|
|
2022
Q4 | $3.15M | Buy |
1,136,845
+400,411
| +54% | +$1.11M | 1.86% | 25 |
|
|
2022
Q3 | $1.89M | Buy |
736,434
+114,453
| +18% | +$293K | 1.94% | 26 |
|
|
2022
Q2 | $2.24M | Buy |
621,981
+96,395
| +18% | +$347K | 2.08% | 27 |
|
|
2022
Q1 | $3.26M | Buy |
525,586
+93,141
| +22% | +$578K | 2.58% | 18 |
|
|
2021
Q4 | $3.05M | Buy |
+432,445
| New | +$3.05M | 2.23% | 22 |
|